Karan, Sweta
Jung, Eunkyeong
Boone, Christine
Steinmetz, Nicole F.
Funding for this research was provided by:
NIH (R01 CA274640, R01 CA224605 and R01- CA253615)
American Cancer Society – F.M. Kirby Foundation Inc. (Mission Boost Grant, MBGI-23-1030244-01-MBG)
Article History
Received: 30 November 2023
Accepted: 15 January 2024
First Online: 13 February 2024
Declarations
:
: The authors declare the following competing financial interests: Dr. Steinmetz is a co-founder of, has equity in, and has a financial interest in Mosaic ImmunoEnginering Inc. Dr. Steinmetz is a co-founder of, and serves as manager of Pokometz Scientific LLC, under which she is a paid consultant to Mosaic ImmunoEngineering Inc., Flagship Labs 95 Inc., and Arana Biosciences Inc.. The other authors declare no potential COI.